Skip to main content
. 2021 Nov 2;11:21425. doi: 10.1038/s41598-021-00954-8

Figure 6.

Figure 6

Results of cell cycle test of MDA-MB-231 cells treated with all formulations (0.259 μg/mL of B2D, 2D, BD, Dox, BC and Conf and 2.59 μg/mL of PB) by flowcytometry method: (A) Histograms of cell cycle distrubution and (B) Quantitative diagram of cell population (%) in different phases of cell cycle (Sub G1, G0/G1, S and G2/M), in presence of all formulations (Abbreviations: PB: blank βCD-g-PMA-co-PLGA micelles, B2D: co-drug loaded βCD-g-PMA-co-PLGA micelles, BD: Dox loaded βCD-g-PMA-co-PLGA micelles, BC: Conferone loaded βCD-g-PMA-co-PLGA micelles, Dox: Free Doxorubicin, Conf: Free Conferone, 2D: Free Doxorubicin-Conferone).